Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Deferred Tax Assets (2016 - 2018)

Medifast's Current Deferred Tax Assets history spans 8 years, with the latest figure at $426000.0 for Q1 2018.

  • For Q1 2018, Current Deferred Tax Assets changed N/A year-over-year to $426000.0; the TTM value through Mar 2018 reached $426000.0, changed N/A, while the annual FY2016 figure was $1.7 million, 41.67% up from the prior year.
  • Current Deferred Tax Assets reached $426000.0 in Q1 2018 per MED's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $3.7 million in Q4 2014 to a low of $426000.0 in Q1 2018.
  • Average Current Deferred Tax Assets over 4 years is $2.0 million, with a median of $2.0 million recorded in 2014.
  • Peak YoY movement for Current Deferred Tax Assets: surged 130.63% in 2014, then plummeted 67.57% in 2015.
  • A 4-year view of Current Deferred Tax Assets shows it stood at $3.7 million in 2014, then tumbled by 67.57% to $1.2 million in 2015, then skyrocketed by 41.67% to $1.7 million in 2016, then tumbled by 74.94% to $426000.0 in 2018.
  • Per Business Quant, the three most recent readings for MED's Current Deferred Tax Assets are $426000.0 (Q1 2018), $1.7 million (Q4 2016), and $1.9 million (Q3 2016).